Stay updated on EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Sign up to get notified when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.

Latest updates to the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe EDP-938 clinical trial record is displayed in place of a 403 error page, showing the study’s design, eligibility criteria, results measures, locations, and documents.SummaryDifference73%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe study record page now displays a 403 Forbidden message and an NIH website transition announcement above the site footer.SummaryDifference2%

- Check34 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov error page displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check62 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating access to the record and related materials is blocked.SummaryDifference17%

Stay in the know with updates to EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.